126 related articles for article (PubMed ID: 4030534)
1. Inability of gentamicin and fosfomycin to eliminate intracellular Enterobacteriaceae.
Kihlström E; Andåker L
J Antimicrob Chemother; 1985 Jun; 15(6):723-8. PubMed ID: 4030534
[TBL] [Abstract][Full Text] [Related]
2. [Fosfomycin, a new antibiotic: in vitro activity compared with mezlocillin, cefuroxime and gentamicin].
Lindenschmidt EG; Schassan HH
Immun Infekt; 1980; 8(4):121-6. PubMed ID: 6453080
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
Pruekprasert P; Tunyapanit W
Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin.
Falagas ME; Maraki S; Karageorgopoulos DE; Kastoris AC; Mavromanolakis E; Samonis G
Int J Antimicrob Agents; 2010 Mar; 35(3):240-3. PubMed ID: 20034765
[TBL] [Abstract][Full Text] [Related]
5. Fosfomycin efficacy and emergence of resistance among Enterobacteriaceae in an in vitro dynamic bladder infection model.
Abbott IJ; Meletiadis J; Belghanch I; Wijma RA; Kanioura L; Roberts JA; Peleg AY; Mouton JW
J Antimicrob Chemother; 2018 Mar; 73(3):709-719. PubMed ID: 29253153
[TBL] [Abstract][Full Text] [Related]
6. Appearance of fosfomycin resistant Rahnella aquatilis clinically isolated in Japan.
O'Hara K; Chen J; Shigenobu F; Nakamura A; Taniguchi K; Shimojima M; Ida H; Yoshikawa E; Tsuboi I; Mizuoka K; Sawai T
Microbios; 1998; 95(381):109-15. PubMed ID: 9872000
[TBL] [Abstract][Full Text] [Related]
7. [Enterobacteria isolated in hospitals. Comparison of the bacteriostatic and bactericidal activity of amikacin, gentamicin and tobramycin].
Kazmierczak A; Gailliard MC; Pothier P; Siebor E; Portier H
Nouv Presse Med; 1979 Oct; 8(42):3399-402. PubMed ID: 537884
[No Abstract] [Full Text] [Related]
8. Susceptibility of clinical isolates to dactimicin and gentamicin.
Bergan T
Drugs Exp Clin Res; 1989; 15(3):109-12. PubMed ID: 2752907
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics of fosfomycin against ESBL- and/or carbapenemase-producing Enterobacteriaceae.
Fransen F; Hermans K; Melchers MJB; Lagarde CCM; Meletiadis J; Mouton JW
J Antimicrob Chemother; 2017 Dec; 72(12):3374-3381. PubMed ID: 29029067
[TBL] [Abstract][Full Text] [Related]
10. [Influence of culture media composition on the interpretation of susceptibility tests to fosfomycin].
Pessione E; Martinetto P; Gaffodio AM; Angeretti A; Giunta C
G Ital Chemioter; 1979; 26(1-2):195-201. PubMed ID: 400138
[No Abstract] [Full Text] [Related]
11. Activity of temocillin and 15 other agents, including fosfomycin and colistin, against Enterobacteriaceae in Hong Kong.
Ip M; Lai CK; Fung KSC; Wong KT; Zhu C; Van de Velde S; Tsang DN; Hawkey P
Eur J Clin Microbiol Infect Dis; 2017 Dec; 36(12):2491-2494. PubMed ID: 28840351
[TBL] [Abstract][Full Text] [Related]
12. The combination of colistin and fosfomycin is synergistic against NDM-1-producing Enterobacteriaceae in in vitro pharmacokinetic/pharmacodynamic model experiments.
Albur MS; Noel A; Bowker K; MacGowan A
Int J Antimicrob Agents; 2015 Nov; 46(5):560-7. PubMed ID: 26387065
[TBL] [Abstract][Full Text] [Related]
13. Fosfomycin: In vitro efficacy against multidrug-resistant isolates beyond urinary isolates.
Demir T; Buyukguclu T
J Glob Antimicrob Resist; 2017 Mar; 8():164-168. PubMed ID: 28167307
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae.
Berçot B; Poirel L; Dortet L; Nordmann P
J Antimicrob Chemother; 2011 Oct; 66(10):2295-7. PubMed ID: 21807739
[TBL] [Abstract][Full Text] [Related]
15. Plasmid-mediated high-level gentamicin resistance among enteric bacteria isolated from pet turtles in Louisiana.
Díaz MA; Cooper RK; Cloeckaert A; Siebeling RJ
Appl Environ Microbiol; 2006 Jan; 72(1):306-12. PubMed ID: 16391058
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro activity of tobramycin and gentamicin on three different media.
Sandven P; Lassen J; Solberg O; Evandt O
Chemotherapy; 1980; 26(5):354-60. PubMed ID: 7389429
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibilities of clinical isolates of carbapenemase-producing Enterobacteriaceae to fosfomycin and tigecycline.
Choudhury S; Yeng JL; Krishnan PU
Clin Microbiol Infect; 2015 Oct; 21(10):e75-6. PubMed ID: 26086572
[No Abstract] [Full Text] [Related]
18. Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae.
Ballestero-Téllez M; Docobo-Pérez F; Rodríguez-Martínez JM; Conejo MC; Ramos-Guelfo MS; Blázquez J; Rodríguez-Baño J; Pascual A
Clin Microbiol Infect; 2017 May; 23(5):325-331. PubMed ID: 28062317
[TBL] [Abstract][Full Text] [Related]
19. Bactericidal activity of tigemonam, alone and in combination with gentamicin.
Shah PM; Gänger-Farshid G; Mulert R; Stille W
J Chemother; 1989 May; 1 Suppl 2():45-8. PubMed ID: 2809703
[TBL] [Abstract][Full Text] [Related]
20.
Sahu M; Saseedharan S; Bhalekar P
Indian J Med Microbiol; 2017; 35(3):437-438. PubMed ID: 29063896
[No Abstract] [Full Text] [Related]
[Next] [New Search]
